Advertisement
Document › Details
Roche. (5/21/18). "Press Release: Roche’s Hemlibra Reduced Treated Bleeds by 96 Percent Compared to No Prophylaxis in Phase III HAVEN 3 Study in Haemophilia A without Factor VIII Inhibitors". Basel.
Region | Glasgow | |
Country | United Kingdom (GB) | |
Organisation | Roche (Group) | |
Product | clinical research | |
Original document
accessed by [iito] on 2018-05-22
Record changed: 2023-06-05 |
Advertisement
More documents for Roche (Group)
- [1] PhoreMost Ltd.. (9/6/22). "Press Release: PhoreMost Enters Multi-project Drug Target Discovery Collaboration with Roche". Cambridge....
- [2] Forbion Capital Partners. (7/20/22). "Press Release: Forbion Appoints Dr. Peter Høngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner". Naarden....
- [3] Bicycle Therapeutics plc. (7/12/22). "Press Release: Bicycle Therapeutics Announces Further Expansion of Genentech Immuno-Oncology Collaboration". Cambridge & Boston, MA....
- [4] Bicycle Therapeutics plc. (21/10/26). "Press Release: Bicycle Therapeutics Announces Expansion of Genentech Immuno-Oncology Collaboration". Cambridge & Boston, MA....
- [5] Roche. (10/18/21). "Press Release: Roche Announces Collaboration with Ibex Medical Analytics to Develop Artificial Intelligence-based Digital Pathology Applications for Improved Patient Care". Santa Clara, CA....
- [6] Atbtherapeutics. (10/20/20). "Press Release: Atbtherapeutics Strengthens Its Scientific Advisory Board to Support the Development of its Novel Platform and Portfolio". Belgium....
- [7] Inflazome Ltd.. (9/21/20). "Press Release: Inflazome Announces Acquisition by Roche". Dublin & Cambridge....
- [8] Inflazome Ltd.. (7/14/20). "Press Release: FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)". Dublin, Cambridge & Brisbane....
- [9] SutroVax, Inc.. (3/26/20). "Press Release: SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia". Foster City, CA....
- [10] Inflazome Ltd.. (3/26/20). "Press Release: Inzomelid Completes Phase I Studies and Shows Positive Results in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)". Dublin, Cambridge & Brisbane....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top